Human leukemia virus--new studies (1981)
Becker, Y.
Harefuah 104(4): 147-149
1983
ISSN/ISBN: 0017-7768 PMID: 6654227 Document Number: 214009
Document emailed within 1 workday
Related Documents
Whang-Peng, J.; Bunn, P.A.; Knutsen, T.; Kao-Shan, C.S.; Broder, S.; Jaffe, E.S.; Gelmann, E.; Blattner, W.; Lofters, W.; Young, R.C. 1985: Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States Journal of the National Cancer Institute 74(2): 357-369Mori, N.; Prager, D. 1996: High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I tax Cancer Research 56(4): 779-782
Aida, Y.; Amanuma, H.; Okada, K. 1994: Identification of tumor-associated antigen that is expressed on bovine leukemia virus-induced lymphosarcoma cells and expression of its human homologue in human T-cell lymphotrophic virus I-infected cell lines Leukemia 8(Suppl): S231-S234
Andzhaparidze, O.G.; Zasukhina, G.D.; Stepanova, L.G.; Matusevich, L.L. 1972: The mechanism of human diploid cell transformation evoked by leukemia-like virus. Enhancement of the transforming activity of the virus by 2,4-dinitrophenol Voprosy Virusologii 17(4): 435-437
Cherney, T.M.; Schultz, R.D. 1996: Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes American Journal of Veterinary Research 57(6): 812-818
Shigematsu, T.; Dmochowski, L.; Williams, W.C. 1971: Studies on mouse mammary tumor virus (MTV) and mouse leukemia virus (MuLV) by immunoelectron microscopy Cancer Research 31(12): 2085-2097
Ohtsubo, H.; Arima, N.; Matsushita, K.; Hidaka, S.; Fujiwara, H.; Arimura, K.; Kukita, T.; Fukumori, J.; Matsumoto, T.; Eizuru, Y.; Tanaka, H. 1997: Human T lymphotropic virus-type I Tax induction of CD21/Epstein-Barr virus receptor expression on T cells and its significance in leukemogenesis of adult T cell leukemia Experimental Hematology 25(12): 1246-1252
Coursaget, P.; Barres, J.L.; Yvonnet, B.; Chiron, J.P.; Cornet, M.; Ferrara, L.; Eyraud, M. 1985: Antibodies to human T-cell leukemia virus (HTLV-1) in non human primates from Senegal Biomedicine and PharmacoTherapy 39(4): 198-199
Shimoyama, M. 1990: Human T-cell leukemia virus type i and adult T-cell leukemia-lymphoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(4 Part 1): 589-600
Mortensen, R.F.; Ceglowski, W.S.; Friedman, H. 1973: Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus Journal of Immunology 111(6): 1810-1819
Colletta, G.; Di Fiore, P.P.; Fusco, A.; Lettieri, F.; Covelli, A.; Peschle, C. 1983: Expression of Friend leukemia virus and spleen focus-forming virus-specific sequences in erythroid bursts and granulocyte-macrophage colonies from spleen and marrow of mice infected with Friend leukemia virus Cancer Research 43(2): 598-603
Sarngadharan, M.G.; Popovic, M.; Bruch, L.; Schupbach, J.; Gallo, R.C. 1984: Antibodies reactive with human t lymphotropic retroviruses human t cell leukemia lymphoma virus iii in the serum of patients with acquired immuno deficiency syndrome Science 224(4648): 506-508
Azocar, J.; Essex, M. 1979: Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus Journal of the National Cancer Institute 63(5): 1179-1184
Matsuoka, M. 2010: Mechanism of oncogenesis by human T-cell leukemia virus type 1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 10-13
Gallo R.C. 1985: Evidence for exposure to human t cell leukemia virus iii in uganda before 1973 Science 227(4690): 1036-1038
Torisu, T.; Masumi, S.; Yamamoto, H. 1992: Human T cell leukemia virus-I carriers and gonarthrosis. A preliminary report Journal of Rheumatology 19(9): 1421-1424
Ablashi, D.V.; Turner, W.; Armstrong, G.R.; Bass, L.R. 1972: Characterization of murine Rauscher leukemia virus propagated in human cells Journal of the National Cancer Institute 48(3): 615-621
Spitzer, G.; Verma, D.S.; Dicke, K.A.; McCredie, K.B. 1978: Culture studies in vitro in human leukemia Seminars in Hematology 15(4): 352-378
Lang, D.J.; Kovacs, A.A.; Zaia, J.A.; Doelkin, G.; Niland, J.C.; Aledort, L.; Azen, S.P.; Fletcher, M.A.; Gauderman, J.; Gjerset, G.J. 1989: Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study Group Journal of Acquired Immune Deficiency Syndromes 2(6): 540-549
Jirjis, F.F.; Davis, T.; Lane, J.; Carritt, K.; Sweeney, D.; Williams, J.; Wasmoen, T. 2010: Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine Veterinary Therapeutics: Research in Applied Veterinary Medicine 11(2): E1-E6